Cancer cells resistant to various anticancer drugs such as Tamoxifen, Oxaliplatin, Cisplatin, Doxorubicin, Etoposide, Imatinib, etc., have been reported to induce drug resistance by activating the NRF2 signalling pathway[23-25]. Here, NFE2L2 is linked to cancer.